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Turmeric / Oregano Extracts as Wound Healing Agents in a Diabetic 
Animal Model 
 
ABSTRACT 
Diabetic wound infections and pressure ulcers pose a significant challenge to healthcare 
providers worldwide. With an increased incidence of chronic skin ulcers and a 
significant financial impact on healthcare systems, reaching $25 billion annually, new 
methods to treat chronic and diabetic ulcers are in great need. The current study 
provides new and innovative wound care products that reduce inflammation, clear 
infection and improve healing time in an animal model of pressure and diabetic ulcers. 
Animal model with excisional wound & pressure ulcer was done on the dorsal side of 
the rats in diabetic and non-diabetic groups. Our results showed that pressure ulcer had 
significantly different pathological features compared to excisional wounds. Diabetes 
caused skin changes that negatively affects the healing process.  
Different turmeric extracts, oregano essential oil and chitosan nanoparticles 
were tested for their antibacterial & antioxidant activity. Results showed that turmeric 
ethanolic extract 5%, oregano essential oil 1% & chitosan nanoparticles 1% had the 
most antibacterial & antioxidant effects. Ointments were synthesized of each herb 
individually. An in vivo pilot study was conducted on diabetic and non-diabetic rats 
with pressure ulcer. Results showed that turmeric 5% ointment successfully healed the 
ulcer in both diabetic and non-diabetic rats by day 15. The oregano 1% ointment 
achieved complete healing by day 15 in the non-diabetic group while in the diabetic 
group was achieved by day 21. 
The above concentrations were incorporated in different forms (ointment, 
amorphous hydrogel & nanofibers). Those forms were tested for their antibacterial, 
cytotoxic effect & in vivo using Tegadermâ (commercial wound dressing) as positive 
control. Our results showed that the designed formulas had significant antibacterial 
effect as Tegadermâ. On testing the formulations on mouse fibroblast cell line (L929), 
ointment & hydrogel were non-cytotoxic while nanofibers showed relative cytotoxicity 
if compared to Tegadermâ that was highly toxic. By testing the formulations in vivo, 
our results showed that by day 15 ointment and nanofibers achieved complete wound 
closure while hydrogel and Tegadermâ did not. 
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Chapter 1 : Literature Review 
 
1.1 Introduction 
Chronic wounds such as diabetic foot infections and pressure ulcers, pose a significant 
challenge to healthcare providers worldwide. Over the past years, the incidence of 
chronic skin ulcers dramatically increased, leading to a huge financial impact on 
healthcare systems, reaching $25 billion annually in the United States (Gainza et al., 
2015; Han & Ceilley, 2017). Skin ulcers cause high morbidity and mortality rates. A 
study conducted in 2011 showed the mortality rate in 2 years follow up of skin ulcer 
patients reached 28% due to chronic skin complications (Escandon et al.,  2011). 
 Diabetes is one of the leading causes for skin infection and chronic ulcers. With 
the prevalence of diabetes increasing worldwide new wound care products are needed 
to reduce healing time and improve patients’ quality of life (Jhamb et al., 2016).  
In the present study, we describe new and innovative wound care product that 
reduce inflammation, clear infection and reduce healing time in an animal model of 
diabetic ulcer. The current model improves the understanding of the healing process 
under different conditions. Using readily available rodents, with low cost and the ability 
to use a relatively large number of animals, making research more appropriate and 
reducing statistical errors (Trujillo et al., 2015; Trostrup et al., 2016). The present model 
avoids the wound contracture characteristic of rodents by compromising the 
subcutaneous muscle (panniculus carnosus), therefore, making the wound more 
clinically relevant to human studies (Wong et al., 2011; Seaton et al., 2015). 
 
1.2 Global Impact 
Chronic ulcers have negative impact on patients, their families, healthcare systems and 
economies as well. They  negatively affect patients’ quality of life, as well as, daily 
lifestyle and job performance (Herber et al., 2007).  
 
Ulcer management is a costly process reaching £5,000 per patient annually (Kapp 
et al.,2017 ; Guest et al., 2016). Chronic skin ulcers also affect patients’ productivity 
leading to an economic impact, besides the huge healthcare expenditure, reaching US 
$25 billion annually (Rahman et al., 2010; Han et al.,  2017).   
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1.3 Healing process in acute and chronic wounds 
The normal healing process of the skin is characterized by the following phases: 
coagulation, acute inflammation, proliferation and remodeling (Khodaeian et al., 2015).  
 
Following acute injury circulating platelets are exposed to collagen leading to 
the activation of coagulation cascade, where fibrinogen is converted to fibrin leading 
to thrombus clot formation (Gilbert et al, 2016). This clot is crucial in protecting the 
wound from infection, as well as preventing further blood loss (Bielefeld et al., 2013).  
Activated platelets release pro-inflammatory cytokines and growth factors that recruit 
inflammatory cells to the site of wound to initiate the inflammatory phase (Gilbert et 
al., 2016; Hameedaldeen et al., 2014).  
 
In the inflammatory phase, neutrophils and macrophages are the key players. 
Neutrophils remove bacteria, foreign objects from the wound, produce proteolytic 
enzymes such as matrix metalloproteinase (MMP) that break down dead tissue  
(Hameedaldeen et al., 2014). Monocytes later differentiate to macrophages that 
phagocytose foreign organisms and dead neutrophils. They also release transforming 
growth factor beta (TGF-ß) and other cytokines, and thereby enhance fibroblasts and 
epithelial cells movement into the wound area  (Bielefeld et al., 2013; Hameedaldeen 
et al., 2014). 
 
The proliferation phase overlaps with the inflammatory phase, and is primarily 
characterized by three major events: angiogenesis; extracellular matrix (ECM) 
synthesis and re-epithelialization (Gilbert et al., 2016; Emanuelli et al, 2016). In the 
proliferative phase, macrophages shift to an anti- inflammatory phenotype expressing 
different anti-inflammatory mediators, proteases and protease inhibitors, and growth 
factors, such as vascular endothelial growth factor (VEGF) and TGF- ß that encourage 
cell proliferation and protein synthesis. Endothelial cells and fibroblasts then 
accumulate in the wound site encouraging occurrence of angiogenesis and fibroplasia, 
providing oxygen, nutrients, for the proliferating cells to form  granulation tissue  
(Tsourdi et al.,2013). 
The remodeling phase is considered the last step of tissue remodeling leading 
to skin recovery. During the remodeling phase, immature ECM and collagen type III 
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are degraded by MMPs and replaced with collagen I (Zhao et al., 2016; Gilbert et al., 
2016; Bielefeld et al., 2013). Subsequently, collagen fibers rearrange they lie closer 
together across tension lines, facilitating cross-linking and thus increases the tensile 
strength of the wound where unnecessary blood vessels and cells undergo apoptosis 
and replaced by normal skin tissue (Emanuelli et al., 2016; Baltzis et al., 2014) (Figure 
1.A). 
 
In chronic skin ulcers, reactive oxygen species (ROS) are the key players. 
Elevated levels of ROS cause oxidative damage in DNA, proteins and lipids leading to 
tissue damage (Donato-Trancoso et al., 2016). They induce inflammation, which in turn 
lead to epithelial dysfunction, decreased reperfusion, impaired angiogenesis resulting 
in poor ulcer healing  (Blakytny et al., 2006). Also chronic skin ulcer is characterized 
by reduced levels of tissue inhibitors of MMPs (TIMPs), the proteins that inhibit MMPs 
activity and as a result elevated levels of  matrix metalloproteinases accelerates  tissue 
degradation  (Baltzis et al., 2014; Amin et al., 2016). MMPs degrade the growth factors 
involved in the healing process as insulin growth factor (IGF-I), TGF- β1, and platelet 
derived growth factor (PDGF) which are crucial for the healing process, thus inhibiting 
ECM & re-epithelization (Falanga, 2005). High concentrations of ROS and low TGF- 
β1 expression level increases macrophage chemo attractant protein-1 (MCP-1) levels, 
which in turn attract greater numbers of macrophage leading to sustained inflammation 
(Blakytny et al., 2009). Impaired angiogenesis is seen in patients with chronic ulcers. 
An angiogenesis-promoting growth factor, hypoxia inducible factor-1α (HIF-1α) is 
induced in response to hypoxia resulting in the transcription of growth factors as VEGF 
which is important for angiogenesis. In chronic ulcers, HIF-1α is down regulated 
leading to low expression of  VEGF  as a result poor angiogenesis and impaired wound 
healing  (Catrina et al., 2004) (Figure 1.B). 
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Figure 1 Overview for Mechanism of Healing in Acute and Chronic Wounds 
A. Acute Wound. After acute injury circulating platelets are exposed to collagen 
leading to the activation of coagulation cascade, where fibrinogen is converted to 
fibrin leading to the formation of thrombus. Activated platelets produce pro-
inflammatory cytokines and growth factors that employ inflammatory cells to the 
wound site to initiate the inflammatory, proliferative & remodeling phases. B. 
Chronic Wound is characterized by hyper inflammation where elevated levels of 
inflammatory cytokines as TNF alpha and IL-1 lead to inhibition of anti-
inflammatory macrophages. Also, in chronic wounds, MMPs are elevated and 
reduced levels of TIMPs accelerate ECM and growth factors degradation all this 
leads to impaired healing process. Adapted from (Larouche et al., 2018).  
 
 
1.4 Types of Chronic wounds 
Chronic skin ulcers have a complex etiology, with a diverse range of 
comorbidities making it difficult to study and find a therapeutic agent. Most chronic 
wounds fall into four main categories: arterial, venous, pressure, and diabetic ulcers 
(Figure 2). In the current study we will focus mainly on pressure ulcers in diabetes 
mellitus (DM). 
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Figure 2 Common Causes of Chronic Wounds 
Diabetic and Pressure Ulcers showed to be the most prevalent types of ulcers among 
all chronic wounds adapted from (Iyun et al,  2016). 
 
1.4.1 Diabetic Ulcers  
Diabetic Ulcers and foot infections are major complications affecting 15–20 % of 
diabetic patients’ worldwide (Emanuelli et al., 2016; Jhamb et al., 2016). According to 
the International Diabetes Federation, in 2015 diabetes affected 415 million patients, 
with an expected increase 642 million by 2040  (Ogurtsova et al., 2017).  Diabetic foot 
management costs nearly 9-13 billion USD annually on top of the management of DM 
itself (Raghav et al., 2018). Foot disorders include ulceration, infection and gangrene 
which are the main causes of hospitalization and in severe cases might lead to further 
disability due to amputation (Ray et al., 2005; Jhamb et al., 2016).  
 
Hyperglycemia and peripheral neuropathy with impaired circulation, increase 
the risk of ulceration (Popov, 2010; Zhao, et. al., 2016). Moreover, diabetes related 
metabolic complications directly disrupt wound healing process (Baltzis et. al., 2014). 
The accumulation of advanced glycation end-products (AGEs) stimulates oxidative 
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stress, and disrupts the normal inflammatory cell function. Poor circulation and poor 
oxygenation are contributing factors to poor healing and chronicity of the wounds in 
diabetic patients (Berlanga-Acosta et al., 2013). 
 
1.4.2 Pressure Ulcers (PU) 
Pressure ulcers (Bed sores), also known decubitus ulcers, are the most common 
example of tissue necrosis  (Roaf, 2006). Most pressure ulcers develop mainly in 
elderly bedridden patients (70%), following strokes, major orthopedic, and spinal cord 
injuries (Tubaishat et al., 2018; Grey et al., 2006). According to the Agency for 
Healthcare Research and Quality's (AHRQ) pressure ulcer affect 2.5 million patients 
per year in the US and cost $9.1-$11.6 billion per year. Skin surface over the bony 
prominences (e.g., hips, ankles, heels, coccyx, scapulae) are the most vulnerable areas 
(Baron et al., 2016 ; Mendoza-Garcia et al., 2015) (Figure 3). Those ulcers are painful 
and prone to infection, which may result sepsis or osteomyelitis (Mendoza-Mari Y et 
al., 2013). There are four main factors that are involved in pathogenesis of pressure 
ulcer which are; pressure, shear, friction, and moisture (Grey et al., 2006). Due to 
continuous pressure the blood supply to the skin is obstructed leading to poor 
circulation resulting in tissue death and an ulcer development (Figure 4). 
According to the National Pressure Ulcer Advisory Panel (NPUAP), pressure 
ulcers are classified into 4 stages; stage 1: regions of intact skin with non-blanchable 
erythema. Stage 2: partial-thickness skin loss with exposed dermis, with pink to red 
viable wound area, and deeper tissues are not visible. Stage 3: full-thickness skin loss 
with adipose tissue seen in the ulcer. Stage 4: full-thickness skin and tissue loss with 
exposed muscle, tendon, ligament, cartilage or bone in the ulcer (The National Pressure 
Ulcer Advisory Panel -, European Pressure Ulcer Advisory Panel, and Pan-Pacific 
Pressure Injury Alliance, 2014) (Figure 5). 
In the early stages, the patient has an intact nervous system, so the pressure is 
painful (stages 1 and 2), Once the epithelium is destroyed the ulcer may be relatively 
painless and can progress rapidly (stages 3 and 4) (Grey et al., 2006). The prevalence 
of high-grade pressure ulcers (grades 3 and 4) may reach 4% in elderly persons (Anders 
et al., 2010). Pressure ulcers may be prevented by changing patient position frequently  
(Nageswaran et al., 2015). 
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Figure 3 Common sites of pressure ulcer 
Figure showing most bony prominences where skin ulcers most likely occur adapted 
from (Grey et al., 2006).  
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Figure 4 Pathophysiology of Pressure Ulcer 
Diagram showing pathophysiology of pressure ulcer, sustained pressure leads to 
decrease of blood flow, resulting in ischemia and fluid escapes to extravascular spaces 
leading to edema and tissue death adapted from (Grey et al., 2006).  
 
 
 
 
 
 
 
 10 
 
 
Figure 5  Stages of Pressure Ulcer 
Stages of Pressure Ulcers according to NPUAP where; Stage 1 Show intact skin non-
blanchable erythema. Stage 2 Partial-thickness skin loss with exposed dermis. Stage 3 Full-
thickness skin loss with exposed adipose tissue. Stage 4 Full-thickness skin and tissue loss 
with exposed muscles, tendons. Adapted from (http://smart.servier.com/) with modifications.  
 
1.4.3 Other types of Ulcers  
Venous Leg Ulcer arise from chronic venous insufficiency in the lower limbs (Guest 
et al., 2018; Comerota et al., 2015). It causes a local rise in blood pressure, leading to 
leakage of macromolecules and red blood cells into the perivascular space. Subsequent 
edema and fibrosis decrease growth factors and oxygen diffusion, therefore, causing 
tissue ischemia (Guenin-Macé et al.,  2014; Morton & Phillips, 2016).  
 
Arterial Ulcers are less common than venous and diabetic ulcers, they occur 
because of arterial insufficiency and poor perfusion, leading to insufficient skin 
oxygenation, and tissue breakdown (Guenin-Macé et al., 2014). 
 Other types of skin ulceration include trauma, burn, and immune dysfunction, 
(Guenin-Macé et al., 2014; Tomioka et al., 2018).  
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1.5 Skin Ulcer Management 
Skin ulcer management and prevention remain a challenge for healthcare (Sibbald et 
al., 2012). Preventive actions include; risk assessment, patient mobility and nutrition, 
skin care and regular pressure redistribution (Langemo et al., 2015). Once the skin is 
damaged action plans should take place, these might include; 
1.5.1 Debridement 
Debridement and removal of necrotic tissues to clean the wound and decrease infection 
(Leaper et al., 2011; Burtis et al., 2009).This can be achieved by surgical/ mechanical, 
or biological methods (Woo et al., 2015; Falabella, 2006). Biological debridement 
involve enzymes, although it may cause inflammation and slowing of the healing 
process (Falabella, 2006). Surgical or mechanical debridement are non-selective, and 
remove viable as well as necrotic tissues (Falabella, 2006). Other types of debridement, 
include Maggot debridement which involves larvae to remove only necrotic tissues 
(Sherman, 2009). 
 
1.5.2 Antimicrobials 
Antiseptics and  topical or systemic antibiotics are the first line of treatment of skin 
ulcers to prevent infection, choice of antibiotic line should depend on culture and 
sensitivity results (Norman et al., 2016; Tsourdi et al., 2013). Extensive use of 
antibiotics in developing countries leads to antimicrobial resistance, and increases the 
risk of more dangerous types and resistant infections  (Ayukekbong et al., 2017). 
 
1.5.3 Topical preparations and Wound Dressings  
Topical Preparations: including antimicrobials, antioxidants, growth factors and 
analgesics are used for wound care (S. Gupta et al.,2017). Although, easy to prepare 
and  low cost, there are not convenient due to the need for multiple applications, and 
wound cover or dressing to protect the wound surface (Lipsky et al., 2009). 
Wound Dressings have been developed to protect the wounds and accelerate 
healing (Han et al., 2017). Choice of dressing depends on the type and location of the 
wound and the quantity of exudates (S. Gupta et al., 2017). The table below shows 
examples of commercially available dressings with their advantages and disadvantages 
(Table 1) 
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Table 1: Examples of commercially available dressings used in wound treatment 
Dressing 
Type 
Commercial 
Examples 
Comments References 
Gauze Vaseline Gauze 
 
• Inexpensive. 
• Cause drying. 
• May cause further damage on changing. 
• Need to be changed frequently. 
(Han et al., 
2017) 
 
(S. Gupta et al., 
2017.) 
Films Bioclusive ® 
Blisterfilm® 
Tegaderm® 
 
• Occlusive & Retains moisture. 
• For non-exudative wounds as it doesn’t 
absorb exudates. 
• Protect against bacteria. 
(Han et al., 
2017) 
 
 
Hydrogels Nu-gel® 
Kikgel® 
Aqua-gel® 
Aquaform® 
 
• Inexpensive.  
• Can be amorphous or sheets. 
• Permeable to Oxygen. 
• Protect from bacteria. 
• Have low tendency to absorb exudates. 
Useful for dry wounds. 
• Help in autolytic debridement. 
(S. Gupta et al., 
2017.) 
(Health Quality 
Ontario, 2009) 
(Sweeney et al., 
2012) 
(Boatenget al.,  
2015) 
Hydrocolloids Aquacel ® 
DuoDERM® 
Tegasorb® 
• Used for dry wound. 
• Occlusive, not used with exudative 
wound. 
• Not for infected wounds. 
(Han et al., 
2017) 
(Sweeney et al., 
2012) 
Foams 
 
3M Adhesive 
Foam® 
Lyofoam® 
 
• Synthetic polymers made of 
polyurethane (May cause allergy) and 
silicone.  
• They have absorptive capacity. 
• Protect against bacteria. 
• They minimize trauma during dressing 
changes. 
(Han et al., 
2017) 
 
(Sweeney et al., 
2012) 
Hydro fibers 
 
Aquacel® 
 
• Made of sodium carboxymethyl 
cellulose (CMC).  
• Have high tendency to absorb exudates. 
• Used for infected wounds. 
• They are inert dressing don’t involve in 
the healing process. 
• Expensive Dressings. 
(Sweeney et al., 
2012) 
 
(Han et al., 
2017) 
 
Alginates 
 
Algisite® 
Kaltostat® 
 
• Do not adhere to the wound.  
• Highly absorbent. 
• Hemostatic.  
• Some patients may feel burning 
sensation this can be due to the rapid 
movement of fluid from wound into the 
dressing.  
• It doesn’t protect against bacteria. 
• Not suitable for dry wounds. 
(Han et al., 
2017) 
 
(Sweeney et al., 
2012) 
 
(Health Quality 
Ontario, 2009) 
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1.5.4 Skin Grafts & Substitutes 
Autologous, full or partial thickness skin grafts have been used for non-healing chronic 
wounds (Han et al., 2017; Serena et al., 2015). 
Recently, tissue-engineered skin substitutes gained importance due to their 
advantages, such as biodegradability, and their promotion of tissues growth, therefore, 
increasing healing rate and improving patient care (Boateng et al., 2015; Maarof et al., 
2016). Some of those substitutes include; Omnigraft accelerates healing in diabetic foot 
and burns (Han et al., 2017). The main disadvantage of these scaffolds is their high cost 
(Han et al., 2017). 
 
1.5.5 Growth Factors 
Growth factors, such as, PDGF,  fibroblast growth factor (FGF) and epidermal growth 
factor (EGF), are promising therapeutic agents in wound healing (Loh et al., 2013).   
Several forms of growth factors have been studied in different types of chronic skin 
ulcers, with variable success, in addition to, their low bioavailability (Barrientos et al., 
2014; Sweeney et al., 2012). 
 
1.5.6 Vacuum Assisted Closure (VAC) 
Vacuum Assisted Closure (VAC), or negative pressure is an effective, noninvasive 
adjunctive therapy that has been in use since 1997 to accelerate chronic skin ulcer 
healing (Han et al., 2017; Nain et al., 2011). Vacuum increases blood flow, enhances 
oxygenation, cellular growth and tissue repair (Schreiber, 2016), as well as enhancing 
wound contraction (Huang et al., 2014).  
These devices limit the patients’ mobility and are noisy. Changing the dressing and 
tube is usually painful and cause bleeding. VAC devices are also not recommended for 
cancer patients, spinal cord injuries or patients on anticoagulants (Schreiber, 2016).  
 
1.5.7 Hyperbaric Oxygen therapy (HBOT) 
High pressure aims to increase the oxygen concentration in the patient’s blood and 
therefore, improving the oxygen supply to the wound. Although HBOT showed 
improvement in wound healing, there are still some doubts, and the high oxygen 
pressure may be harmful to the brain (Tuk et al., 2014; Van Neck et al., 2017; Han et 
al., 2017). 
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1.6 Phytomedicine in treatment of skin ulcers 
Natural medicinal plant extracts have been widely used as topical applications for 
wound healing. Aloe vera,  Echinacea , Chamomile, Ginseng, Ginkgo, Green tea and 
olive oil, as well as, many other plants were found to be effective in wound healing 
(Pazyar et al., 2014). Several research groups across the world showed that 
phytochemicals available in natural herbs might help in treating inflammatory 
conditions and might aid in wound healing and skin regeneration (Thangapazham et al., 
2016). Phytochemicals protect the skin by suppressing free radicals and inhibition of 
nuclear factor kappa B (NF-κB) leading to reducing inflammation. Phytochemicals also 
affect other signaling pathways, including transforming growth factor-beta (TGF-β). 
Extensive research is needed to clarify the molecular targets and mechanisms of 
phytochemicals will lead to the development of effective formulations (Shah & Amini-
Nik, 2017). In the current study, we will discuss how turmeric extract and oregano 
essential oil will help in wound healing. 
 
Turmeric (the golden spice), is derived from the rhizome of Curcuma longa. 
Turmeric has shown antioxidant, anti-inflammatory, anticancer, antidepressant, anti-
aging, antidiabetic, antimicrobial, wound healing effect (Figure 6) (S. C. Gupta et al., 
2012). The main component of turmeric is curcumin, which was thought to be 
responsible for all biological activities. Recent studies identified new compounds other 
than curcumin. It became unclear that those activities are through curcumin or due to 
other compounds or synergistically of both. Those compounds showed to have anti-
inflammatory and anticancer effect (Figure 7) (Aggarwal et al., 2013). 
 
Curcumin was found to be effective in wound healing in diabetic and non-
diabetic animal models and in animals subjected to γ-radiation (Jagetia et al., 2004) 
(Mani et al., 2008). Phan et al. (2001), showed that curcumin has inhibitory activity 
against hydrogen peroxide-induced oxidative damage in human keratinocytes and 
fibroblasts.  Cheppudira et al. (2013),  showed that curcumin could be a potential 
natural therapy to control severe pain associated with burn.  
 
Turmeric contain different proteases that might aid in stopping bleeding 
(Shivalingu et al.,  2015). Sarafian et al. (2015), proposed that turmeric micro-emulgel 
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may be considered  a therapeutic option for many patients suffering from plaque 
psoriasis. Other research showed that turmeric extracts has a potential therapeutic role 
in spinal cord injuries (Kamel et al., 2017). Meizarini et al. (2018), showed that wound 
dressing consisting of a combination of zinc oxide and turmeric extract proved to be 
effective as an anti-inflammatory. Lone et al. (2018), showed that turmeric extract 
accelerated healing of dry socket alveolar osteitis following tooth extraction.  
 
 
Figure 6 Medicinal Uses of Turmeric 
Turmeric was found to be helpful in treatment of chronic diseases, such as psoriasis, 
inflammatory diseases as inflammatory bowel disease, and also proved to be helpful in 
wound healing adapted from  (Aggarwal et al., 2007). Its low toxicity and side effects 
and its availability in large quantities in cheap prices make it a suitable therapeutic 
agent.  
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Curcumin has anti-inflammatory and anti-oxidative properties therefore, it may 
affect many molecular targets involved in inflammation, oxidative stress. It inhibits 
arachidonic acid metabolism, and downregulate enzymes as lipoxygenase (LOX), 
cyclooxygenase 2 (COX2) and inducible nitric oxide synthase (iNOS).  As a result, it 
blocks the synthesis of prostaglandin (PG), and cytokines, e.g. interleukin (IL), and 
tumor necrosis factor (TNF). Curcumin also promotes the release of steroidal hormones 
from the adrenals. Further studies are needed to reveal the molecular targets of different 
Turmeric extract components (Figure 8) (Rao et al., 2007). 
 
 
 
Figure 7 Non- Curcumin Components of Turmeric   
Turmeric has a range of constituents other than curcumin that exert anti-inflammatory 
effect and thus help in wound healing adapted from (Aggarwal et al., 2013). 
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Figure 8 Anti-inflammatory & Anti-oxidant Mechanism of Curcumin 
Curcumin suppresses inhibitory unit Ik-Bα, which hinders subsequent nuclear 
translocation of the functionally active subunit of NF-kB, inhibiting the inducible nitric 
oxide synthase (iNOS) as a result inhibit nitric oxide leading to decreased expression 
of cyclooxygenase 2 (COX2) suppressing inflammation. Curcumin also inhibits 
lipoxygenases (LOX) resulting in suppressing leukotriene, which are inflammatory 
mediators. Adapted from (Rao et al., 2007). 
 
Oregano is essential oil obtained from leaves of Origanum vulgare family 
Lamiaceae (Olmedo et al.,2014). The main components of oregano are the phenols 
isomers carvacrol and thymol, as well as their precursor monoterpenes γ-terpinene and 
p-cymene (Sakkas et al., 2017). Oregano shows antimicrobial, antifungal, anti-
inflammatory and antioxidant effects (Ragi et al., 2011; Chun et al., 2005; Rosato et 
al., 2009). The antimicrobial effect was found to be at concentration less than 2% 
(Boateng et al., 2015).  
 
1.7  Nanomaterial in Wound Care 
Nanomaterial reduce drug toxicity, enhance solubility of hydrophobic drugs, increase 
drug penetration, provide controlled  release of the drugs, increase their stability and 
protect them from being degraded (Goyal et al., 2016 ; Wang et al., 2011). 
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Nanofibers are considered one of the dressings that offer great advantages over 
current dressings. Electrospun nanofibers possess high surface area, porosity and have 
structure that mimic the ECM (Chen et al., 2017). Current research focuses on reducing 
inflammation and infection, therefore, creating positive environment for wound healing 
(Chen et al., 2017). Recent uses of nanofibers for wound healing include; loading 
growth factors to promote angiogenesis and accelerate wound healing rate, polyaniline-
chitosan nanofibers to enhance cell attachment and proliferation, silver nanoparticles 
(AgNPs) incorporated in collagen nanofibers to decrease wound infection rates and 
accelerated closure (Moutsatsou et al., 2017; Rath et al., 2016; Xie et al., 2013).  
 
Nanoparticles used for wound-healing applications are often made of polymers 
that have been used previously as wound dressings (Kalashnikova et al., 2015). 
According to literature there are different means for nanoparticles absorption through 
skin (Figure 9) (Palmer et al., 2016).  
 
Chitosan is considered one of the most widely used biopolymers for 
nanoparticles preparation. This is due to its biodegradability, biocompatibility, low 
toxicity (Kamat et al., 2016). Chitosan has adhesive character the advantage that make 
them promising and wound healing agents this is beside their antibacterial and 
antifungal effect (Katas et al. 2013; Wang et al., 2011). Chitosan nanoparticles (ChNP) 
are synthesized using non-toxic solvents as they are soluble in acidic medium 
(Agnihotri et al., 2004). It was found that ChNP have higher antibacterial activity than 
chitosan and chitin. This is due to the spherical character of NP, and the positive charge 
of  ChNP interact with the negatively charged surface of bacteria resulting in membrane 
disruption, leakage  of intracellular components and cell death (Divya et al., 2017). All 
these benefits make them promising nanocarrier for drug delivery (Prabaharan, 2015). 
Chitosan nanoparticles were loaded on calcium alginate hydrogel to reduce 
inflammation and improve neovascularization (T. Wang et al., 2017), and were 
incorporated in polycaprolactone nanofibers to improve wound healing (Jung et al., 
2015). 
From our point of view, the only limitation of nanomaterials either nanofibers 
or nanoparticles is the difficulty of large-scale commercial production. More research 
is needed to move nanomaterials for wound healing from laboratory to the market 
(Zafar et al., 2016; Chen et al., 2017). 
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Figure 9 Mechanisms of Nanoparticle penetration through skin 
Based on particle size, charge, morphology and polymer type, nanoparticles can 
penetrate skin through the 1) Appendageal route, as hair follicles, sweat glands. 2) 
Intracellular route through corneocytes 3) Intercellular route were particles pass 
between corneocytes. Adapted from (Palmer et al., 2016). 
 
1.8 Wound healing Models 
Wound healing models are essential to study the pathogenesis of wound healing and to 
identify molecular targets, as well as, to test new therapeutic approaches (Sami et al., 
2019; Ud-Din & Bayat, 2017). Wound models can be designed in silico, in vitro, ex 
vivo and in vivo using computational, cell culture, wound biopsies, and animal models 
(Wilhelm et al., 2017; Andrade et al., 2015; O’Dea et al., 2012).  In vitro models are 
used to test new drugs, and scaffolds but do not provide a clear view of the biological 
interactions in a living organism, as they lack innervation and circulation that play 
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critical role in the healing process (Andrade et al., 2015; Wilhelm et al., 2017; Ud-Din 
& Bayat, 2017).   
 
In vivo models are the most efficient wound healing models. They can either be 
human, small or large animals. Human model has the advantage of testing new drugs 
in clinical trials, their disadvantages include; the difficulty to obtain patients with 
chronic wounds and the lack of uniformity of the wound type and microbial 
composition (Ud-Din & Bayat, 2017). Animal models offer the best alternative. Large 
animals such as pigs have great advantages, as they have skin type similar to the human 
skin, and the main method of healing is through re-epithelization (Volk et al., 2013), 
although some wound contraction occurs in some sites. The disadvantage of using pigs 
is that they have significant high cost, and therefore hard to do replicates that provide 
statistical significance (R. Perez  et al., 2008). 
Rodents are the most commonly used animals for wound healing models due to 
their availability, low cost and small size, which makes it easy to include a relatively 
large number of animals, which provides statistical significance and decreases error 
(Trostrup et al., 2016). A great disadvantage of rodent use for chronic wounds is that 
they have unique panniculus carnosus layer, which causes rapid wound contraction 
(Wong et al., 2011), in addition to the significant differences in their immune systems 
compared to humans, which limits the usefulness of these models (Seaton et al., 2015).  
 
In the current study, we describe a new model that mimics chronic pressure ulcer 
in human to address the shortcomings of other rodent wound models and overcome 
wound contraction due to the panniculus carnosus muscle.  
 
Infected and chronic wounds are difficult to treat especially in diabetic patients due 
to bacterial resistance and excessive use of antibiotics. We describe a novel 
combination of antibacterial agents from Turmeric/ Oregano/ Chitosan nanoparticles. 
 
1.9 Hypothesis 
We hypothesize that our designed formula will be non-cytotoxic, anti-inflammatory, 
antioxidant, will clear wound infection, and improve wound healing, in diabetic animal 
model. 
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1.10 Objectives 
Our objectives in the current study are; 
1. Develop a deep pressure ulcer model in a diabetic animal and highlight the 
difference between excisional wound and pressure ulcer healing process in 
normal and diabetic animals. 
2. Design a cost-effective formulations (ointment/amorphous hydrogel/ 
Nanofibers), for chronic skin ulcers using turmeric, oregano and chitosan 
nanoparticles. 
3. In vitro and in vivo testing of the newly designed formulations, for cytotoxicity/ 
antibacterial, and wound healing efficacy.   
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Chapter 2 : Materials & Methods 
Materials  
Streptozotocin (Sigma- Aldrich, USA). Ketamine and Xylazine Hydrochloride, 
Ketoprofen, magnets (3 g weight, 15 mm diameter and 250 Gauss magnetic force). 
Citric acid, Sodium citrate buffer (Al-Nasr Chemicals, Egypt), 5% glucose solution 
(Al-Nasr Chemicals, Egypt). Chitosan Molecular weight 600,000 – 800,000 (Acros 
Organics, Belgium), Tripolyphosphate (TPP; Mistral chemicals UK). Glucometer (Free 
Style, Abbott, USA9), 99% acetic acid (Sigma- Aldrich, USA), Sodium Hydroxide (Al 
Nasr Chemicals), Deionized water (DI), Turmeric ethanolic extract (Herb pharm, 
USA), Turmeric CO2 Organic Oil Extract (plant Therapy, USA), and Oregano Essential 
Oil (plant Therapy, USA), Difco Nutrient Broth, Difco Nutrient Agar (Thermo Fisher, 
German), Staphylococcus aureus (S. aureus), Escherichia coli (E. coli), petrolatum 
(Eva cosmetics), Polyvinyl Alcohol (PVA) “Mowiol 20-98” Mol. Wt = 125,000 (Sigma 
Aldrich, Germany). Dulbecco’s Modified Eagles Media with L-glutamine (DMEM), 
Alkaline Phosphate buffer (PBS), trypsin & Pen/Strep (Lonza, Belgium), Dimethyl 
sulfoxide (DMSO; Sigma Aldrich), Acetic acid (Sigma Aldrich), Fetal Bovine Serum 
(FBS) (Life Science group, UK), Thiazolyl blue tetrazolium bromide (MTT; Serva 
Electrophores, Germany), Tegaderm patches (3M) FDA approved patches for diabetic 
foot ulcers (U.S. FDA Resources). 
 
Methods 
2.1 Development of Pressure Ulcer in a Diabetic Animal Model 
 
Animal handling: Male Sprague-Dawley rats weighing ≈150-200 grams, were housed 
under standard 12 h light/ 12 h dark conditions with free access to water and food. All 
procedures were performed in compliance with the national institute of health (NIH) 
guidelines for the Care and Use of Laboratory Animals, and in compliance with the 
guidelines established by the Institutional Animal Care and Use Committee (IACUC) 
of the October University for Modern Sciences and Arts (MSA) ethical committee.  
 
Rats were anesthetized with intraperitoneal (I.P) injection of ketamine/Xylazine 
(ketamine 80-100 mg/kg, xylazine 10-12.5 mg/kg IP mg/kg), according to IACUC 
guidelines. Hair was clipped and rat skin was cleaned using Betadine®. Rats were 
 23 
randomly divided into either control or experimental groups. The first group received 
a full thickness excisional wound (12-15 mm2) extending through the panniculus 
carnosus using surgical scissors. In second group a sterilized magnet (3 g weight, 15 
mm diameter and 250 Gauss magnetic force) was inserted deep to the panniculus 
carnosus muscle layer. An external magnet of the same dimensions was placed on the 
skin surface. Both magnets were kept until necrosis of the sandwiched layer of skin and 
both magnets fell producing an ulcer extending to the subcutaneous tissue.  
A third group of animals were intraperitoneally injected with streptozocin (STZ) to 
induce diabetes according to the method described by (Furman et al., 2015) with 
modifications. After confirmation of diabetes, these animals also received a skin ulcer 
using the method described above.   
Macroscopic clinical assessment and photographs of the wounds were performed at the 
time of surgery and on subsequent days. Wound evaluation using ImageJ® software 
was performed at regular time intervals. Parameters such as; depth, granulation tissue, 
and infection were assessed using scoring system adapted from (Martínez-De Jesús et 
al., 2010; Perez et al., 2010; Y. Huang et al., 2015; Strauss et al., 2016), with 
modifications. Each parameter received a score (zero= Healed, 1 minimal, 2 mild, 3 
moderate, and 4 Severe). 
Histopathological sections stained with hematoxylin and eosin (H&E) and masson 
trichrome stain, slides were examined and photographed using a BX51 light microscope 
(Olympus xc 30, Tokyo, Japan) and scored according to the scoring system originally 
described by (Gal et al., 2008). 
 
2.2 Chitosan Nanoparticles 
2.2.1  Preparation of Chitosan solution  
Chitosan solution  of concentrations (0.05%, 0.1%, 0.2%, 0.3% (w/v)) were prepared 
by stirring chitosan in an aqueous acetic acid solution (1% (v/v)) overnight at room 
temperature. The pH of Chitosan solution was adjusted to 4.8 using 1 N NaOH (Kheiri 
et al., 2017). 
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2.2.2 Preparation of Chitosan Nanoparticles  
Chitosan nanoparticles were prepared through ionotropic gelation as described by 
(Calvo et al.,1997). Briefly, tripolyphosphate (TPP) solution of concentration 1 mg/ml 
was added dropwise to chitosan solution at ratio TPP : Chitosan (1:3)  under vigorous 
magnetic stirring at room temperature 900 rpm for 30 minutes (Kheiri et al., 2017). 
Opalescent solution was formed as indicator for nanoparticles formation. Nanoparticles 
were collected by centrifugation (Eppendorf 5804 R) for two hours at speed 11,000 rpm 
and temperature 4oC. Supernatants were discarded, and the particles were washed twice 
with deionized water and centrifuged for 15 minutes in each cycle. Nanoparticles (NPs) 
were finally re-dispersed in deionized water. Particles were kept in ice and sonicated 
for 3 minutes using probe sonicator (Branson Sonifier 150). Finally, particles were 
lyophilized (Biobase BK-FD10S ) and stored at -20oC for further use. 
 
2.2.3 Nanoparticles Characterization 
2.2.3.1 Hydrodynamic Size, Zeta Potential & Polydispersity Index 
Nanoparticles (NPs) suspension was diluted with de-ionized (DI) water to a 
concentration 1 mg/ml before analysis. The hydrodynamic diameter (HD) and zeta 
potential (ZP), polydispersity index (PDI) were measured using a Malvern Zetasizer 
Nano ZS90 (Malvern Instruments Ltd, UK). All samples were analyzed in triplicates at 
25°C and results were expressed as mean ± standard deviation.  
 
2.2.3.2 Morphological Assessment 
Primary morphological analysis was performed visually using inverted light 
microscope (Olympus 1X70).  
For advanced nanoparticles morphological analysis, a diluted drop of NP 
suspension (2 mg/ml) was spread on a glass slide and allowed to dry overnight at 
room temperature. Prior to imaging samples were coated with a fine gold layer 
using a gold sputter module for 90 seconds at 10 KV (JEOL JFC-1600 Auto fine 
coater, Japan). Samples were examined using scanning electron microscopy (SEM: 
FESEM, Leo Supra 55, Zeiss Inc., Oberkochen, Germany). 
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2.3 Antibacterial Test 
Serial dilutions were used to evaluate the antibacterial activity of the chitosan 
nanoparticles & herbal extracts (turmeric ethanolic extract, turmeric CO2 organic oil 
extract, and oregano essential oil), against gram positive and gram-negative bacterial 
strains, Staphylococcus aureus and Escherichia coli respectively. The concentration of 
chitosan nanoparticles tested were 5 mg/ml (0.5%), 10 mg/ml (1%), while the 
concentrations of extracts used were 0.1%, 0.5%, 1%, 5% & 10% of each extract.  
Each bacterial strain was added to nutrient broth and kept overnight in shaker incubator 
(Innova 43). The optical density (OD) was adjusted to of 0.1 at wavelength of 625 nm 
using spectrophotometer (Ultrospec 3100 pro). Extracts and nanoparticles were 
sterilized under UV for 1.5 hours, samples were added to bacteria and incubated in 
shaker incubator overnight (Innova 43). The samples as well as the controls were 
serially diluted and spread on nutrient agar, which were then incubated overnight at 
37oC.  The experiment was performed three times in triplicates & the surviving colonies 
were counted and compared to the control. Results were expressed in % bacterial 
reduction according to the below equation; 
% bacterial reduction = (1-T/C) *100 
Where T is cfu/mL of test sample and C is cfu/ml of control. 
 
2.4  Anti -Oxidant Assay 
3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) Assay 
The concept of this test depends on the reduction of the yellow tetrazolium salt to the 
purple crystals of formazan by antioxidant compounds (Muraina et al., 2009). Briefly; 
Tegaderm®, oregano, turmeric essential oil, and turmeric ethanolic extracts, were 
dissolved either in DMSO or DMEM to a final concentration of 1%, 5%, while chitosan 
nanoparticles were suspended at concentrations of 0.5%, 1% and incubated at 37oC in 
shaker incubator overnight. Herbal extracts and chitosan nanoparticles were placed in 
96 well plate (Grenier Bio). 20 µl of 5 mg/ml of MTT was added to each well and the 
plate was incubated for 3 h at 37°C. Media were removed and DMSO was added to 
solubilize the formazan blue crystals. The optical absorbance was measured at 570 nm 
using a plate reader (SPECTROstar Nano, BMG Labtech, Ortenberg, Germany).  
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2.5 Ointment Formulation 
Petrolatum was used as a vehicle to carry herbal extracts. Briefly; oregano, turmeric 
ethanolic extracts were levigated with petrolatum to form an ointment, concentrations 
were 1%, 5% respectively. Ointment preparation was stored at room temperature until 
use. 
 
2.6 In vivo Pilot study 
A pilot study to assess healing efficacy of turmeric and oregano was performed on 
pressure ulcer in diabetic and non-diabetic rats. Briefly, 5% turmeric ointment and 1% 
of oregano ointment was applied once a week. Macroscopic examination and scoring 
were done to determine their effect on the healing process. Parameters such as ulcer 
area, depth, granulation and inflammation, granulation and infection were investigated 
with the following scoring system originally described by Martínez-De Jesús, 2010, 
and Gupta & Kumar, 2015, with modifications: 0 = Healed; 1= minimal; 2= mild; 3= 
moderate; and 4= Severe. 
 
2.7 Formulation Preparation 
2.7.1  Ointment 
Petrolatum was used as a vehicle to carry herbal extracts and chitosan nanoparticles. 
Briefly, oregano, turmeric ethanolic extracts and chitosan nanoparticles were levigated 
with petrolatum to form concentrations 1%, 5% and 1% of each item respectively.  
2.7.2 Amorphous Hydrogel 
Polyvinyl alcohol (PVA) of concentration 12% was prepared by dissolving PVA in 
deionized water in the autoclave at temperature 121o C for 15 minutes. After cooling, 
herbal extracts of oregano, turmeric and chitosan nanoparticles were added to reach 
final concentrations of 1%, 5% and 1% respectively. The mixture was stirred at room 
temperature for 1 hour. The solution was filled in syringes and stored at room 
temperature for further use. 
2.7.3 Hydrogel Sheet 
The amorphous hydrogel was poured in a petri dish and physically cross-linked through 
repeated cycles of freeze-thawing (He et al., 2018; Kamoun et al., 2015). The plate was 
stored in -50o C overnight, followed by 8 cycles of freeze-thawing were applied (1 hour 
freezing at -50o C followed by thawing at room temperature for 30 minutes).  
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2.7.4 Xerogel 
The hydrogel sheet was freeze dried (Biobase BK-FD10S ) for 10 hours to obtain 
Xerogel (Niknia & Kadkhodaee, 2017). 
2.7.5 Nanofibers preparation 
Polyvinyl alcohol of concentration 12% was prepared by dissolving PVA in DI water 
for 3 hours at temperature 90oC. After cooling, herbal extracts added to a final 
concentration of turmeric 5%, chitosan nanoparticles 1% and oregano 1%, and stirred 
for 1 hour at room temperature. The polymer was then finally electrospun by applying 
voltage 14, 16 & 18 KV and flow rate 0.8 ml/hr, 1.1 ml/hr & spinning distance 12 cm, 
needle diameter was 21G. 
2.8 Nanofibers Characterization 
The electrospun fibers were characterized morphologically using (SEM: FESEM, Leo 
Supra 55, Zeiss Inc., Oberkochen, Germany). Prior to imaging, samples were coated 
with fine gold layer using a gold sputter module for 90 seconds at 10 KV (JEOL JFC-
1600 Auto fine coater, Japan). The fibers were checked for beads & the average 
nanofiber diameters were determined using ImageJâ software. For each of the 
developed nanofibrous mats, 100 fibers were measured, and the average diameter was 
calculated. 
2.9 Antibacterial Test for the designed Formulas 
The antibacterial activity of the preparations, using Tegaderm® as positive control was 
evaluated against both gram positive and gram-negative bacterial strains, 
Staphylococcus aureus and Escherichia coli respectively. Each strain was added to 
nutrient broth and kept overnight in shaker incubator (Innova 43). The optical density 
(OD) was adjusted to of 0.1 at wavelength of 625 nm using spectrophotometer 
(Ultrospec 3100 pro). The preparations were sterilized in ultraviolet radiation (UV) for 
1.5 hours and incubated in shaker incubator overnight with the bacterial strains. The 
samples, as well as the controls were serially diluted and spread on nutrient agar which 
were then incubated at overnight at 37oC. The experiment was performed in triplicates 
and the surviving colonies were counted and compared to the controls. Results were 
expressed in % bacterial reduction according to the following equation; 
% bacterial reduction = (1-T/C) *100 
Where T is cfu/mL of test sample and C is cfu/ml of control. 
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2.10 In vitro Biocompatibility 
2.10.1 Cytotoxicity 
 
Effects of the prepared formulas on cell viability was evaluated on of L929 cell line 
(ATCC®), using the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide] assay.  The assay depends on the concept of reduction the yellow tetrazolium 
salt to the purple crystals of formazan, due to the effect of dehydrogenase enzymes that 
are released by the mitochondria of the living and active cells (Patravale et al., 2012). 
The number of viable cells present is directly proportional to the amount of purple 
formazan crystals developed.  
 
Briefly, the prepared forms (ointment, hydrogel, nanofibers) as well as Tegaderm® 
(positive control) were sterilized by UV, and conditioned media were prepared by 
soaking different weights (10 mg, 20 mg) of the preparation in DMEM, containing , 5 
% antibiotic Pen-Strept and 10% FBS for one day in shaker incubator (Innova 43) at 
37o C. 
Cells were seeded in clear 96-well plates (Grenier Bio) at a density of 5,000 cells/well 
and incubated 24 h to allow cell attachment. The conditioned media were filtered 
through 0.2µm syringe filters and added to the cells. The cells were then incubated with 
the conditioned medium of each formulation using Tegaderm® as positive control & 
cells without any treatment as negative control for 24 hours. Following incubation, the 
medium was removed and replaced with new one, MTT prepared according to 
manufactures instructions (Serva Electrophores, Germany) was added and cells were 
incubated for 3 h. Finally, the medium was removed and DMSO was added to dissolve 
the formazan crystals. The absorbance was measured at 570 nm using a microplate 
reader (SPECTROstar Nano, BMG Labtech, Ortenberg, Germany). The test was 
repeated eight times in triplicates for each preparation. Cell viability (%) was calculated 
based on the following equation:  
!"#$%$&' #&() %= (Ab *&+,')	570 nm −.b b'&/0	570 nm) / (.b 12/(#2'	570 nm −.b 3'&/0	
570 nm)×100 
Where Ab sample is the sample absorbance, Ab blank is the absorbance of blank, Ab 
control is the absorbance of the control.  
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2.10.2 Cell Morphological Examination 
Following incubation with treatment as described above, the cells morphology was 
examined using inverted microscope (Olympus 1X70). 
2.11 In vivo Testing for the designed Preparations 
2.11.1 Macroscopic Examination 
In vivo study was done to assess healing efficacy of the designed formulations on 
diabetic pressure ulcer model (described previously) in comparison to Tegadermâ as 
positive control. All formulations were applied once a week. Macroscopic (clinical) 
examination was performed to evaluate wound healing. 
2.11.2 Histological Examination 
At days 10, and 15 of treatment, rats were euthanized with an overdose of pentobarbital 
(Thiopental sodium) 75 mg/kg, IP, and skin samples collected and fixed in 10% 
paraformaldehyde, paraffin embedded, and 5 µ sections were cut and stained with 
hematoxylin and eosin to assess inflammatory cells and granulation tissue, collagen 
deposition was assessed using masson trichrome staining (Olympus xc30. Tokyo. 
Japan).  
 
Semi-quantitative method was used to evaluate following histological processes and 
structures: re-epithelization, polymorphonuclear leucocytes (PMNL), fibroblasts, new 
vessels, and new collagen. Sections were evaluated according to the scale: 0, 1, 2, 3, 4. 
Parameters for histological assessment were adapted from  (Gal et al., 2008). 
Table 2:  The semi-quantitative evaluation of histological sections 
 (ST – Surrounding Tissue, i.e. tissue out of GT; DL – Demarcation Line; SCT – 
Subcutaneous Tissue; GT – Granulation Tissue). 
 
Scale Epithelization PMNL Fibroblasts New vessels Collagen 
0 Thickness of cut edges absent absent Absent absent 
1 Migration of cells (< 50%) mild ST mild ST mild-SCT minimal-GT 
2 Migration of cells (≥ 50%) mild DL/GT mild-GT mild-GT mild-GT 
3 Bridging the excision moderate DL/GT moderate-GT  moderate-GT  moderate-GT  
4 keratinization marked DL/GT marked-GT  marked-GT  marked-GT  
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2.12 Statistical Analysis 
The statistical analysis were done using GraphPad PRISM software version  8.02 
(Graphpad Inc., San Diego, CA, USA). All data were expressed in mean ± standard 
deviation. The tests used to test significance were multiple t- test, one way analysis of 
variance test (ANOVA) & 2- way ANOVA. In all analysis, P-value < 0.05 was 
considered statistically significant. Post hoc tests were done to confirm where 
differences occurred between groups. 
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Chapter 3 : Results & Discussion 
 
3.1 Development of Pressure Ulcer in a Diabetic Animal Model 
 
Based on our results, pressure ulcers showed significant differences compared to 
excisional wounds. The produced ulcer using the magnet method was a full thickness 
skin ulcer extending to the subcutaneous tissue, similar to an ulcer of the third degree 
that develops in human. 
The pressure ulcer produced showed impaired healing and high infection rates, as well 
as the development of fibrous connective tissue that impairs the healing process. These 
ulcers provide an excellent model to study chronic wound healing. In diabetic rats the 
ulcers showed significant changes due to the diabetic pathological changes in the skin 
as well as impairment of the healing process (Figure 10).  
Our conclusion was, that the diabetic pressure ulcer model is very useful to study the 
impaired healing process, and to study the effect of new therapeutics for chronic 
wounds (DG Sami et al, submitted 2019). 
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Figure 10 Graphical representation for Development Of Pressure Ulcer in Rodents  
Rats were injected intraperitoneally with Streptozotocin. 1.) Diabetes was confirmed through  A.I) Fasting Blood Glucose level as diabetic group 
showed significant increase in blood glucose level if compared to the non-diabetic group that showed normal levels. A.II) On Body Weight  
diabetic group showed significant reduction in body weight if compared to the non-diabetic group. B.) Hematoxylin & Eosin of Pancreas showed 
destruction of islets of Langerhans in diabetic group while non-diabetic group showed normal islets 2.) Pressure Ulcer was developed through 
implanting magnet below the panniculus carnosus muscle and another magnet was applied above the skin while the other side served as excisional 
wound in both non-diabetic & diabetic groups. B.I) After a week both magnets fell leaving pressure ulcer. B.II)  Masson Trichrome stain for 
the necrotic skin (sandwiched skin between magnets)  showed sloughing of epidermal layer and hyalinosis of dermal layer. 3.) Macroscopic 
Assessment was done to compare between excisional wound & pressure ulcer in non-diabetic rats & Pressure ulcer in diabetic rats. Pressure Ulcer 
showed impaired healing if compared to excisional wound  that was completely healed by day 21. Diabetic Pressure Ulcer didn’t show healing by 
day 21.4) Microscopic Examination of Skin Biopsies  A.I) Hematoxylin & Eosin stain to assess degree of inflammation between groups. A.II) 
Masson Trichrome stain to assess collagen formation between groups. (Adapted from DG Sami et al., 2019 submitted for Publication).
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3.2 Chitosan Nanoparticles Characterization 
3.2.1 Hydrodynamic Size, Zeta Potential & Polydispersity Index 
The mean particle size for chitosan nanoparticles showed a significant increase with 
increasing concentrations of chitosan from 0.1% to 0.3% (p-value < 0.0001) (Figure 
11). At a concentration of 0.05 %, chitosan particle size was very high (around 5000 
nm). This might be due to insufficient chitosan to react with TPP (results not displayed).  
This is consistent with  Liu & Gao et al. (2008), who reported that the size of chitosan 
nanoparticles depends on different factors one of them was chitosan concentration.  
 
 
 
 Figure 11 Chitosan Nanoparticles hydrodynamic average size 
There is significant increase in average particle size with increase chitosan 
concentration from 0.1% to 0.3% (P-value < 0.0001; n= 3 in triplicates). 
 
Zeta potential was measured to study the stability of particles. Particles with zeta 
potential greater than (>|30| mV) were considered stable, as particles exert electric 
repulsion to avoid its aggregation (Kheiri et al.,2017). In agreement with this concept, 
our particles formed at concentrations 0.1%, 0.2% & 0.3% showed high zeta potential 
suggesting their stability for longer period of time (Table 3).  
 
Poly dispersity index (PDI) is an important parameter when assessing uniformity of 
nanoparticles in solution, larger PDI values indicates larger size distribution & may 
indicate also aggregation (Clayton et al., 2016). Samples with PDI less than 0.5 indicate 
narrow size distribution & high homogeneity (Al-Qushawi et al., 2016). Our results 
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showed that our samples are highly homogenous with PDI of 0.3 for concentrations 
0.1%, 0.28 for concertation 0.2% & 0.26 for 0.3%  (Table 3).   
It is notable that the hydrodynamic diameter (Z-average) of the particles measured by 
dynamic light scattering (DLS) is higher than the size estimated from microscopy 
because of the high swelling capacity of chitosan. Therefore, microscopic evaluation 
through scanning electron microscopy (SEM) or transmission electron microscopy 
(TEM) is necessary to determine actual particle size and asses its morphology (Kheiri 
et al.,2017).  
Table 3: Effect of Chitosan Concentration on Hydrodynamic Size, Zeta Potential & 
Polydispersity Index 
 
Chitosan Conc. 
Parameter 
0.1% 0.2% 0.3% 
Z- average (nm) 265 ±11 335 ±43 381 ±30 
Zeta Potential (mv) +51±3 +49±7 +54±2 
PDI 0.3 0.28 0.26 
 
According to literature, there is no specific particle size for skin penetration as 
nanoparticles can penetrate skin through various mechanisms (Zhang et al., 2013). 
Previous research showed that smaller particles showed more skin penetration 
compared to large particle size that was trapped on the surface in inflamed skin model 
(Try et al., 2016). Retinol encapsulated chitosan nanoparticles of sizes ranges from 50-
200 nm were used for treatment of  skin wrinkles, acne (Kim et al., 2006). Also, 
chitosan encapsulating acyclovir with average size 350-700 nm for treatment of herpes 
was tested in vitro (Hasanovic et al., 2009). Chitosan nanoparticles with small particle 
size showed more antibacterial activity than large ones, due to increase in the surface 
areas which would be in direct contact with the bacteria (Katas et al., 2011).  
Based on this data and results of hydrodynamic size, we selected chitosan nanoparticles 
formed at concentration 0.1% as they showed least particle size and stability (zeta 
potential) for further testing (Figure 12). 
 
 
 36 
 
 
 
Figure 12   0.1 % Chitosan Nanoparticles average size, PDI & stability. 
Average Particle size distribution of 0.1% chitosan nanoparticles was 255 nm, in 
homogenous (monodisperse) solution PDI 0.2. B) The results showed particles of 
high stability with zeta potential (+51 mv). 
 
3.2.2 Morphology Characterization 
Morphology of nanoparticles under inverted microscope with average size 400-500 µm, 
this size was not accurate as the particles were swollen (Figure 13). Therefore, further 
assessment of morphology using SEM was important to give accurate insight about the 
actual morphology, size & aggregates (Singh et al., 2016). SEM revealed spherical 
uniform nanoparticles with average diameter 77 nm & almost no aggregates (Figure 
14). 
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Figure 13 Morphology of Chitosan nanoparticles under light microscope 
(Magnification 100 X) 
A) Rounded chitosan nanoparticles (Black arrows).  B) The average size of 
nanoparticles under inverted microscope was 400-500 µm. 
 
 
 
Figure 14 Morphology of Chitosan nanoparticles through SEM 
A) Rounded chitosan nanoparticles of almost uniform size (Black arrows) with no 
aggregates can be seen. B) The average size of nanoparticles through SEM showed 
to be nearly 77 nm. 
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3.3 Antibacterial Test  
Oregano essential oil was found to be very potent against both gram positive and gram-
negative bacteria at a concentration of 0.1%, it showed 100% bactericidal effect 
(Figure 15, 16). This agrees with previous reports who found oregano to be powerful 
at concentration less than 2% (Hammer et al., 1999). It was hypothesized that essential 
oils of oregano cause disruption of bacterial cell membrane, blocking their enzyme 
system & disrupt ion exchange leading to cell death (Sakkas et al., 2017). 
Turmeric ethanolic extract, caused total bacterial inhibition at concentrations of 0.1% 
against S. aureus, and 5% against E. coli. To exclude the effect of ethanol, turmeric oil 
supercritical CO2 extract was used. Total inhibition of both S. aureus & E.coli at 5% 
was observed (Figure 15, 16). 
 
Turmeric exerts its antibacterial activity through disruption of bacterial membrane 
(Tyagi et al., 2015). It was noted that E. coli were less sensitive to turmeric extracts 
compared to S. aureus. This agrees with previous reports, that showed Gram negative 
(E. coli) were less susceptible due to the presence of lipopolysaccharide in their outer 
membrane (Th et al., 2010).  
ChNP showed increase in bacterial inhibition with increasing concentration from 0.5% 
to 1%. They were found to be more potent against gram positive rather than gram 
negative (Figure 17). Divya et al., (2017) also reported that ChNP showed more 
inhibition on S. aureus than  E. coli. 
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Figure 15 Effect of Oregano, Turmeric Extracts against S. aureus 
A. Oregano & turmeric extracts (ethanolic / supercritical CO2) showed 
antibacterial effect against S. aureus at very low concentration (0.1%). B. 
Graphical representation of the results expressed in % bacterial reduction 
(P<0.0001 ; n = 3 in triplicates). 
 
Control 0.1% 0.5% 1% 5% 10% A. 
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Figure 16 Effect of Oregano, Turmeric Extracts against E. coli 
A. Oregano showed antibacterial effect against E. coli at very low concentration 
(0.1%). Turmeric ethanolic extract was more potent than turmeric oil, both 
showed total bacterial inhibition at concentration 5%. B. Graphical 
representation of the results expressed in % bacterial reduction (P<0.0001 ; 
n=3 in triplicates). 
Control 0.1% 0.5% 1% 5% 10% A. 
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A.   
 
 
B. 
 
 
Figure 17 Effect of Chitosan nanoparticles on Gram positive & Gram-Negative 
Bacteria 
A. Chitosan nanoparticles showed significant increase in antibacterial activity with 
increased concentration from 0.5% to 1%, in both gram positive (S. aureus) and 
gram negative (E. coli). Chitosan nanoparticles were found to be more effective 
on Gram positive more than Gram negative bacteria (P<0.0001). B. Graphical 
representation of the results expressed in % bacterial reduction (P<0.0001). 
Control 0.5% 1 % 
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3.4 Anti - Oxidant Assay  
Oregano showed significant increased antioxidant activity with increasing the 
concentration. This agreed with previous literature that proved that the antioxidant 
effect of  oregano was due to the presence of the high phenolic content (Chun et al.2005; 
Stanojević et al.,  2018). Turmeric ethanolic extract showed more antioxidant power 
than that of turmeric extracted by supercritical CO2 (p-value < 0.0001). This suggests 
that the curcumin and the phenolic content might be higher in the ethanolic extracts. 
This hypothesis agreed with previous reports that ethanol extraction enhanced phenol 
and curcumin extraction (Martinez-Correa et al., 2017). Chitosan NP did not show 
significant antioxidant activity at different concentrations (Figure 18). This is in 
agreement with previous reports that found free Chitosan NP did not exhibit antioxidant 
effects. Only after encapsulation with Quercetin chitosan showed high antioxidant 
effect through scavenging of 1,1-diphenyl-2-picryl-hydrazyl radical (DPPH) radical 
(Y. Zhang et al., 2008). 
 
When the herbal extracts were suspended in DMEM media, significant increase in MTT 
reduction was observed (P-value < 0.0001). This can be due to the interaction between 
the phenolic groups in the extracts with the nutrients in the media that enhanced the 
MTT reduction to give its formazan blue color (Figure 18). Previous study showed that 
flavonoids in media influenced MTT reduction in the absence of cells (Talorete et al., 
2006). 
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Figure 18  Antioxidant Effect of Herbs, ChNPs 
Oregano showed significant increase in antioxidant activity with increase in the 
concentration. Turmeric ethanolic extract 5% was more potent than turmeric 
supercritical CO2 extract (P -value < 0.0001). Turmeric ethanolic extract 5% was more 
potent than turmeric ethanolic extract 1% (P -value < 0.0001). ChNPs showed no 
significant antioxidant activity. Media enhanced MTT reduction in the presence of 
phenolic compounds of the herbs (P-value < 0.0001). 
 
From the results of the antibacterial and antioxidant assays, we decided to use 
oregano at concentration of 1%, turmeric ethanolic extract at a concentration of 
5% & ChNPs at a concentration 1%. 
 
Upon testing the above combination for their antioxidant activity against Tegaderm® 
wound dressings. We found that our combination showed significant anti-oxidant 
activity if compared to Tegaderm® that did not show any antioxidant power (P-value < 
0.0001) (Figure 19). Oregano and turmeric extracts are rich in phenolic compounds 
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that have great effect as antioxidants (Bordoloi et al., 2016; Nakatani et al., 2000). 
Tegaderm® is calcium alginate dressing with silver. To date there is no test to assess its 
antioxidant activity. Our results reveal that Tegaderm® has no antioxidant effect. This 
can be due to the fact that silver act as strong oxidizing agent so, it didn’t affect MTT 
(Syper et al, 1967 ; Pubchem). 
 
 
 
Figure 19 Antioxidant Effect of Combination  
Combination of 1% oregano, 5% turmeric ethanolic extract & 1% ChNP showed 
significant antioxidant activity if compared to Tegaderm® that didn’t have any oxidant 
power (P-value < 0.0001). 
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3.5 In vivo Testing 
3.5.1 Pilot study for Herbs Macroscopic Evaluation  
Turmeric ointments (5%) showed improvement in the pressure ulcer healing process in 
both diabetic and non-diabetic rats. Granulation tissue was greatly enhanced with 
complete healing achieved by day 10 in non-diabetic rats, while complete healing was 
achieved by day 15 in diabetic rats. 
Although oregano 0.1% showed great antibacterial effect in vitro on both gram positive 
and gram-negative bacteria, this concentration was not effective as an anti-
inflammatory on wounds. Therefore, the concentration was increased to 1% only to 
avoid irritation. This concentration was found to be potent anti-bacterial  In vivo. It also 
dramatically improved granulation tissue formation with complete closure of the ulcer 
achieved by day 15 in non-diabetic animals, while in the diabetic rats healing was 
achieved by day 21 (Figure 20). 
One previous study showed the effect of using  3% oregano ointment for wound healing 
in patients with surgical excision. The study revealed significant reduction in bacterial 
infection on post-surgical wounds and improved the scar appearance compared to 
petrolatum (Ragi et al., 2011). 
 
Turmeric extract 5 % ointment showed significant improvement in granulation and 
decreased infection, compared to no treatment groups in both diabetic and non-diabetic 
animals, achieving full wound closure by day 15 (Figure 20). Many researchers used 
curcumin to asses wound healing, a recent study showed that ointment containing 5% 
& 10% curcumin ethanolic extracts showed improved wound healing against an aspirin 
retarded wound healing process (Pawar et al., 2015). Other studies showed that 
curcumin applied in pluronic F127 gel, accelerated wound closure in mice (Yen et al., 
2018). Petrolatum containing 5% turmeric ethanolic extracts enhanced healing at the 
episiotomy incision site in primiparous women. It decreased the period of healing from 
14 days to10 days (Tara et al.,2009).  
 
Our findings showed that, both oregano 1% and turmeric 5% ointments had advanced 
reduction in the healing time, and improved granulation & decreased infection in both 
diabetic and non-diabetic rats. However, oregano scored better in clearing infection 
compared to turmeric. On the other hand, turmeric enhanced the granulation tissue 
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formation more than oregano (Figure 21). To date, there is no comparative study 
conducted between oregano and turmeric to assess their healing activity. 
 
Recent studies showed that chitosan nanoparticle loaded calcium alginate hydrogel 
demonstrated significant antibacterial activity & accelerated wound healing in vivo (T. 
Wang et al., 2018). 
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Figure 20 Photographic images to the extent of wound healing activity of Herbal 
extracts.  
Untreated group, the diabetic group showed higher infection rates, more crusty and 
poor wound healing compared to the non-diabetic group. Turmeric treatment group 
showed complete healing by day 15 in both non-diabetic & diabetic groups. Oregano 
treatment group showed low infection, with complete healing by day 15 in non-diabetic 
group and day 21 in the diabetic group.  
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Figure 21 Effect of Herbs on Pressure Ulcer in Non-Diabetic and Diabetic Rats 
 Both 5% Turmeric & 1% Oregano reduced ulcer area in both models compared to the control group (No treatment). Turmeric 5 % had effect on 
granulation tissue macroscopically compared to the control group (No treatment). Oregano 1 % reduced infection macroscopically compared to 
the control group (No treatment). 
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3.6 Preparation Selection 
 
The formulas that were selected for further studies were the ointment, amorphous 
hydrogel & nanofibers. The hydrogel sheet & xerogel were excluded from the study. 
The hydrogel sheet was tested in vivo and it created a dry tough layer that impaired the 
healing process (results not shown) (parhi et al, 2017; Kumar & Han, 2017). After the 
hydrogel sheet was dried through lyophilization to form xerogel, the product shrank, 
became very dry & lost its elasticity. Previous studies showed that upon PVA 
lyophilization deformation happened, collapse of the pores which affect negatively cell 
growth, therefore, limiting the use of xerogels (Yabin Zhang et al., 2015; Annabi et al., 
2010). 
3.7 Nanofibers Characterization 
 
Based on the results of SEM, we chose to work with flow rate 0.8 ml/ hr as higher flow 
rates showed formation of beads (Figure 22). According to the literature, lower flow 
rates were more suitable as the solvent will have enough time for evaporation (Annabi 
et al., 2010). On analyzing the average fiber diameter of different voltages using 
ImageJâ software, we decided to use 18KV, as it showed high frequency distribution 
of narrow fiber diameters & the fiber diameter mean was 211 nm (Figure 23). This can 
be attributed to the high level of jet stretching in relationship to increased charge 
repulsion within the jet and a strong external electric field (Pillay et al., 2013). 
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Figure 22 Effect of Flow rate on fiber Morphology 
High flow rate 1.1 ml/hr resulted in the formation of beads (arrow), unlike the lower rate 0.8 ml/hr (red box) that produced uniform smooth 
fibers. 
 
 
 
51 
 
 
Figure 23 Effect of Different Voltages on fiber diameter distribution 
Higher voltage (18 KV) resulted in increase in the frequency distribution of the narrow fiber diameter (average Diameter= 211± 115 nm) (red box).
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3.8 Antibacterial Test for the designed Formulations 
 
According to the antibacterial results, our formulations in ointment, hydrogel & 
nanofibers showed significant antibacterial effect on both gram positive & gram-
negative bacteria (P-value < 0.0001). They showed antibacterial activity the same as 
the positive control (Tegadermâ). Although nanofibers had antibacterial effect, it was 
lower than that of the ointment & hydrogel (Figure 24). This can be due to the sustained 
release the nanofibers provide for the incorporated extracts (Weng & Xie, 2015). 
Another hypothesis is that electrospinning decreased the efficacy due to the volatility 
of the herb extracts. In agreement with previous studies, free petrolatum and free PVA 
did not show any antibacterial effect on both strains (Kawai & Hu, 2009; Hu & Wang, 
2016; Gemeda et al., 2018).  
 
 
 
Figure 24 Effect of different forms on Gram Positive and Gram-Negative Bacteria 
A. Bacterial Panel: Treatment ointment, hydrogel showed significant reduction on 
both S. aureus & E. coli as Tegaderm (positive control). Nanofibers also showed 
significant bacterial reduction in both strains but less than the ointment & hydrogel. 
Pure petrolatum & PVA didn’t show any antibacterial effect. B. Graphical 
representation for the results (*P-value < 0.0001 ; n=3 in triplicates). 
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3.9 In Vitro Biocompatibility 
3.9.1 Cytotoxicity 
 
Cell viability (MTT) assay of L929 cells was performed to assess the cytotoxicity of 
the preparations on fibroblast cell line. Tegaderm®  was used as a positive control, and 
cells without any treatment as negative control (Figure 25). Quantitative determination 
by MTT method showed that ointment, and hydrogel were not cytotoxic, the two 
formulations led to a significant cell viability increase compared with viability of the 
no treatment cells (negative control) (p-value < 0.0001). Tegadermâ was significantly 
toxic causing 90% cell death (p-value < 0.0001). The high cytotoxic effect of 
Tegadermâ could be attributed to the silver that the dressing contains. Previous studies 
showed that silver based dressing exhibited significant cytotoxic effects on both 
cultured keratinocytes and fibroblasts (Burd et al., 2007; Hiro et al., 2012). 
 
Nanofibers, on the other hand showed almost 50% reduction in cell survival rate in a 
concentration dependent manner (p-value < 0.05) (Figure 25).The significant reduction 
in cell viability of nanofibers compared to the ointment, and hydrogel (p-value < 
0.0001) can be attributed to reduction of particle size to nanoscale, which makes them 
more cytotoxic than microscale particles (Bhattacharya et al., 2012;Sahu et al., 2016).  
According to literature, the reduction in particle size leads to increase in the surface 
area which makes the number of molecules more exposed and thus show high 
reactivity. As a result, Reactive Oxygen Species (ROS) are produced which cause 
oxidative stress, inflammation and consequently result in DNA and protein damage 
(Khalili Fard et al., 2015). 
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Figure 25 Effect of Different treatment forms on L929 cell Viability 
Tegaderm treated cells (+ve control) showed significant reduction in cell viability if 
compared to untreated cells (P-Value < 0.0001). Both ointment and hydrogels showed 
significant increase in cell viability if compared to untreated cells (P-Value < 0.0001). 
All formulations had significant better viability than Tegaderm treated cells (P-Value 
< 0.0001). Nanofibers showed significant reduction in cell viability compared to the 
negative control (P-Value < 0.0001). Nanofibers showed significant reduction in cell 
viability in concentration dependent manner (P-Value < 0.05; n=8 in triplicates). 
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3.9.2 Cell Morphology  
 
Microscopic examination of the L929 cell cells under microscope 24 hrs post-treatment, 
showed significant changes in cell morphology. Untreated cells (negative control) 
showed a majority of spindle shaped cells adherent to the culture plate (Figure 26.A). 
Tegaderm treated cells appeared rounded, and shrunken cells with no proliferation 
(Figure 26.B). Ointment and hydrogel treated cells at different concentrations showed 
normal spindle shaped cells with increased proliferation (Figure 26.C-F). Nanofiber 
(10 mg/ml) treated cells showed changes in the morphology, with some cells appeared 
rounded with reduced proliferation (Figure 26.G). Nanofiber (20 mg/ml) treated cells 
showed severe changes and most cells appeared rounded and shrunken with reduction 
in proliferation (Figure 26.H). Results of cell morphological assessment agree with 
cell viability MTT assay results.
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Figure 26 Effect of Different treatment forms on mouse Fibroblast (L929) cell line 
Morphology of fibroblast cell line (L929) after 24 hours 
A) Control culture (-ve control) showed spindle shaped & rounded cells (arrow); B) Cells treated with Tegaderm (+ve control) showed rounded 
damaged cells (arrow); Cells treated with ointment combination (10 mg/ml) (C) and  (20 mg/ml) (D) showed normal cell morphology; Cells 
treated with Hydrogel combination (10 mg/ml) (E) and (20 mg/ml) (F) showed normal cell morphology; Cells treated with Nanofibers (10 
mg/ml) (G) showed altered cell morphology (arrow); while those treated with Nanofibers (20 mg/ml) showed rounded cells (H, arrow). 
(Magnification X200) (n=8 in triplicates)
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3.10 In Vivo Testing for the designed Formulations 
3.10.1 Macroscopic Examination 
 
Macroscopic (clinical) assessment of pressure ulcer in diabetic rats, showed that 
Tegaderm® caused poor healing and high infection compared to the other groups tested, 
by day 21 the ulcer size was relatively smaller compared to the control (Figure 27). 
Previous studies, showed that silver containing dressing prevented fibroblast 
proliferation, which impaired wound healing (Burd et al., 2007). Our in vitro 
assessment also supported this finding (Figure 26.B). 
Amorphous hydrogel, according to some authors encourages autolytic debridement of 
necrotic tissue. They work through rehydrating hard eschar and slough tissue and thus 
promote the healing process (Dabiri et al., 2016). Our current results showed the 
opposite, animal group treated with hydrogel showed a high rate of infection, very poor 
healing and by day 21 the wound area was almost similar to that of the control group 
(Figure 27). This can be attributed to the high-water content in the hydrogel, that made 
it rich environment for growth of bacteria. Recent studies showed that amorphous 
hydrogels exhibit poor bacterial barrier (Kamoun et al, 2017). 
 
Animals treated with either ointment or Nanofibers showed very good healing, and low 
infection, compared to the control, complete wound closure occurred by day 15 while 
the untreated group till day 21 didn’t show complete healing (Figure 27). 
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Figure 27 Macroscopic Assessment for the effect of Different Treatment forms on 
Diabetic Pressure Ulcer 
Control group (no treatment) showed high infection, high fibrous connective tissue, and 
no healing by day 21. Tegaderm (+ ve control) and hydrogel treated rats showed poor 
healing and high infection. By day 21 Tegaderm treated rats showed smaller wound 
area compared to the no treatment group. Animals treated with ointment and those 
treated with nanofibers showed complete healing by day 15 (n= 4-6). 
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3.10.2 Histological Examination 
10 Days following treatment, ointment & nanofibers treated groups showed migration 
of basal epithelial cells (Figure 28. C, E).  While untreated group, Tegaderm® treated 
group and hydrogel treated group showed thickening of epidermal layer with necrotic 
tissue (Figure 28. A, B, D).  Masson trichrome staining showed moderate mature 
collagen formation in ointment & nanofibers treated groups if compared to other groups 
(Figure 29 C, E). 
At day 15 following treatment, histological evaluation of the treatment groups showed 
that in the no treatment (-ve control) group, the gap was covered by thick layer of 
necrotic tissue, and inflammatory cell infiltration was evident. The dermal layer showed 
new blood vessel formation (angiogenesis) and fibroblast proliferation that produced 
moderate pattern of granulation tissue (Figure 28.F). Masson’s trichrome stained 
section showed moderate mature collagen fibers (Figure 29.F). 
Tegaderm treated group (+ ve control), showed a gap covered by a thick layer of 
necrotic tissue. Inflammatory cells infiltration was seen as focal aggregation in 
epidermal and dermal layers. The dermal layer showed new blood vessel formation 
(angiogenesis) and fibroblast proliferation to produce moderate pattern of granulation 
tissue (Figure 28.G). Masson’s trichrome stained tissue section showed moderate 
mature collagen fibers (Figure 29.G). 
In the ointment treatment group, the gap was covered by keratinization epithelial cell 
layer with fewer numbers of inflammatory cells infiltrating mainly macrophages. The 
dermal layer showed new blood vessel formation and fibroblast proliferation to produce 
moderate pattern of granulation tissue (Figure 28.H). Masson’s trichrome stained 
tissue section showed marked mature collagen fibers (Figure 29.H). 
Hydrogel treatment group showed a gap with thickening of epidermis by necrotic 
tissues at its cut edges with mild inflammatory cells infiltration mainly macrophages. 
The dermal layer showed angiogenesis and fibroblast proliferation to produce marked 
pattern of granulation tissue (Figure 28.I). Masson’s trichrome stained tissue section 
showed marked mature collagen fibers score (Figure 29.I). 
Nanofibers treatment showed a gap covered by non-keratinization epithelial layer 
with few numbers of inflammatory cells infiltration mainly macrophages. The dermal 
layer showed angiogenesis and fibroblast proliferation producing a moderate pattern of 
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granulation tissue (Figure 28.J). Masson’s trichrome stained tissue section showed 
marked mature collagen fibers score (Figure 29.J). 
According to histological scoring results at day 15, ointment and nanofibers showed 
best results compared to the negative and positive control. Better scores went to the 
ointment as it showed keratinization, low infection and decreased angiogenesis which 
were signs of complete healing (Table 4). This can be due to the rapid release of the 
herbal extracts and chitosan nanoparticles from the ointment, while nanofibers provide 
a slower sustained release. A previous study showed that, the release of vitamin-loaded 
as-spun fiber mats showed gradual release over the test periods, while the 
corresponding cast films exhibited a burst release of the vitamins (Taepaiboon et al., 
2007).
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Figure 28 Effects of Different treatment forms on Diabetic Pressure Ulcer (H&E)  
10 Days post treatment the no treatment diabetic ulcer skin tissue sections (A) showed thickening of epidermis by necrotic tissues (arrow). Tegaderm treated group 
(B) showed angiogenesis accompanied with fibrin thrombi (arrow). Ointment treated group showed (C) bridging of ulcer by epithelial cells (arrow). The Hydrogel 
treatment group (D) showed necrotic tissues at its cut edges (arrow). The Nanofibers treatment Group (E) showed migration of basal epithelial cells (< 50%), (arrow). 
15 Days post treatment the no treatment diabetic ulcer (F) showed moderate pattern of granulation tissue (arrow). The Tegaderm treated group (G) showed focal 
aggregation of Inflammatory cells (arrow). Ointment treated group (H) showed keratinization epithelial cell layer (arrow). Hydrogel treatment (I) showed mild 
inflammatory cells infiltration (arrow). And the Nanofibers treated Group (J) showed non-keratinization epithelial layer (arrow). Magnification (X 200) (n=4-6). 
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Figure 29 Effects of Different treatment forms on Diabetic Pressure Ulcer using Masson Trichrome  
10 Days post treatment, the no treatment diabetic ulcer (A) and hydrogel treatment group (D) showed minimal mature collagen fibers (arrow). While, the 
Tegaderm treated group (B) showed mild mature collagen (arrow). Both ointment treated (C) and nanofibers treated (E) groups showed moderate mature collagen 
fibers (arrows).  
At Day 15 the no treatment  diabetic ulcer (F) and the Tegaderm treated (G) groups showed moderate mature collagen fibers (arrows). While, the ointment treated 
group (H) and the nanofibers treatment (J) showed marked mature collagen fibers (arrows). The hydrogel treatment group (I) also showed marked mature collagen 
fibers (arrow). Magnification (X 200) (n=4-6).
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Table 4 Semi-quantitative Histological Scoring at Days 10, 15 
 
Group/ Day Epithelization PMNL Fibroblasts New vessels Collagen 
10 15 10 15 10 15 10 15 10 15 
No Treatment (-ve Control) 0 0 4 3 1 3 2 2 1 3 
Tegaderm (+ve Control) 0 0 4 3 1 3 3 3 3 3 
Ointment 3 4 2 1 3 3 3 1 3 4 
Hydrogel 0 0 4 2 3 3 4 2 2 3 
Nanofiber 1 3 2 1 3 3 2 2 4 4 
 
Scoring results showed that ointment and nanofibers treatments had dramatic effect on 
re-epithelization with the ointment showing better scores. The inflammatory infiltration 
PMNL were greatly reduced in the ointment, and nanofibers treated groups compared 
to the other groups. Angiogenesis was notably reduced in the ointment treated group 
which indicates complete healing. All formulas; ointment, Nanofibers & hydrogel 
enhanced collagen formation. 
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Chapter 4 : Conclusion & Future Perspectives 
 
 
In conclusion, bed sores & diabetic skin infections are considered burden to 
healthcare & economies. In order to avoid excessive use of antibiotics and bacterial 
resistance, natural herbs provide good alternative as antibacterial and wound healing 
agents. From our results we found that turmeric, oregano extracts provide promising 
antibacterial agents, possess anti-inflammatory effect and act as natural antioxidants. 
The antibacterial and antioxidant tests showed that turmeric ethanolic extract 
5%, oregano essential oil 1% & chitosan nanoparticles 1% had the most antibacterial 
& antioxidant effects. Ointments were formulated of each herb individually. An  in vivo 
pilot study was conducted on diabetic and non-diabetic rats with pressure ulcer. Results 
showed that turmeric 5% ointment successfully healed the ulcer in both diabetic and 
non-diabetic rats by day 15. The oregano 1% ointment achieved complete healing by 
day 15 in the non-diabetic group while in the diabetic group was achieved by day 21. 
The above concentrations were incorporated in different forms (ointment, 
amorphous hydrogel & nanofibers) and were tested in the current study in comparison 
to commercially available wound dressing Tegadermâ (FDA approved dressing for 
treatment of leg ulcers). The best formula was found to be ointment followed by 
nanofibers. The prepared formulas showed significant antibacterial effects. On testing 
the formulas on L929 mouse fibroblast cell lines, ointments and hydrogels were non-
cytotoxic and enhanced significantly cell proliferation. Nanofibers showed almost 50% 
reduction in cell viability while Tegadermâ were significantly toxic (90%) to the cells. 
In vivo results showed complete wound closure in 15 days, which suggest a great 
potential for further clinical applications for these formulations in chronic wounds and 
diabetic ulcers. 
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Future Directions  
 
Encapsulation of turmeric and oregano extracts in chitosan nanoparticles will 
be of great value as they will provide sustained released for the extracts, protect them 
for oxidation. This is beside that they will protect the volatile oils from being degraded 
and as a result increasing their shelf life and retaining their function. Other advantage 
of encapsulation can be overcoming the stain that turmeric causes which limits its 
usage. Also, those formulated encapsulated nanoparticles can be embedded in spray 
form or biodegradable wound dressings to provide protective effect to the ulcer beside 
its healing effect. 
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